The Mosquito Map Trap: Why Surveillance Without Strategy is Just Expensive Cartography

AI-generated image · US National Wire
Opinion: As climate change pushes invasive species north, the push for expanded mosquito monitoring risks prioritizing the act of counting insects over the delivery of actionable public health interventions.
In the world of health tech, there is a recurring phenomenon I call the 'map trap.' It is the tendency for policymakers to believe that if they can simply map a problem with enough granularity, the solution will spontaneously emerge from the data. Currently, we are seeing this play out in the fight against expanding mosquito ranges in the United States.
As Ars Technica first reported, climate change is transforming historically temperate regions like New England into viable habitats for invasive species. In Connecticut, a statewide monitoring program has already identified 54 different species, including the Asian tiger mosquito, which is capable of transmitting Zika and dengue. Philip Armstrong, chief scientist at the Connecticut Agricultural Experiment Station, notes that these species are creeping into areas where they were not historically found.
On the surface, the argument for more monitoring is an easy sell. Armstrong argues that testing mosquitoes is essential to identify 'hot spots' for viruses before human cases appear, at which point he says it is usually too late to act. This is the logic driving the current push for more comprehensive surveillance, including a proposed bill in the New York State Legislature to replace what is currently described as a 'sparse' system with a comprehensive surveillance program.
But as someone who tracks biotech and health tech for a living, I find the current approach concerning. The technology being deployed here is rudimentary—traps using 'stinky water' or dry ice to attract insects—yet the cost is immense. As Ars Technica points out, these programs are labor-intensive, requiring teams to manually set and check traps and specialists to sort and test samples. In some rural parts of New York, the infrastructure is so lacking that teams have had to manufacture their own dry ice.
My concern is not that we aren't spending enough, but that we are spending it on the wrong end of the equation. We are investing heavily in the *detection* of the problem without a clear, scalable framework for the *intervention*.
Take the current state of U.S. surveillance. Dan Markowski of the American Mosquito Control Association has highlighted the need for a national surveillance database to share information across the 'patchwork quilt' of more than 1,000 local mosquito control agencies. Brian Leydet, who studies mosquito- and tick-borne diseases at the State University of New York College of Environmental Science and Forestry, said surveillance programs are often run by counties that do not communicate with one another. This lack of coordination means invasive species can fly under the radar even while we are spending public funds to look for them.
When we look at the diseases in question, the stakes are high. Since it first appeared in the U.S. in 1999, West Nile virus has caused more than 3,300 deaths and is now the leading cause of mosquito-borne disease in the Northeast. Then there is Eastern equine encephalitis, which carries a roughly 30 percent fatality rate. As Leydet observes, environmental changes are creating complex ecological shifts involving hosts like deer and birds, making the problem even harder to track.
However, if the primary goal of these investments is simply to tell us that the Asian tiger mosquito has moved into a new zip code, we are essentially paying for an expensive map of where the mosquitoes already are. Data for the sake of data is not a public health strategy; it is a ledger of decline.
To move beyond the map trap, we need to stop treating surveillance as the end goal. The real metric of success should not be how many species we identify in Connecticut or how many traps we set in New York, but how that data translates into immediate, actionable epidemiological interventions. If we are merely documenting the 'cycles of increased virus activity' that Armstrong attributes to climate change without a coordinated national response, we aren't preventing outbreaks—we are just documenting them in high resolution.
Prevention, as Leydet correctly notes, cannot happen if we only respond once a problem is already a problem. But true prevention requires more than just a database; it requires a shift from passive monitoring to active mitigation. Until the U.S. moves past this fragmented, county-by-county approach and integrates its data into a functional national strategy, these monitoring programs risk becoming little more than expensive exercises in counting the insects that are already winning.

